Target intelligence / Profile preview

Naphthalene 1,2-dioxygenase subunit alpha (NDO alpha subunit)

Target
NDO alpha subunit
Molecular classification
Enzyme, Rieske non-heme iron oxygenase, Aromatic-ring-hydroxylating dioxygenase, Oxidoreductase (EC 1.14.12.12)
01

Overview

Naphthalene 1,2-dioxygenase subunit alpha is the large oxygenase component of the naphthalene dioxygenase (NDO) multicomponent enzyme system found in certain bacteria (notably *Pseudomonas* species). This subunit houses both a Rieske [2Fe-2S] iron–sulfur center, which accepts electrons from a ferredoxin, and a mononuclear nonheme iron active site responsible for catalysis. The enzyme initiates soil and water microbial degradation of polycyclic aromatic hydrocarbons (PAHs), including naphthalene, by catalyzing stereospecific cis-dihydroxylation of the aromatic ring. It is highly studied for its broad substrate range, regiospecificity, and use in bioremediation and biocatalysis. The alpha subunit operates within an \u03b1_3\u03b2_3 hexameric structure and interacts with smaller beta subunits. Despite structural and mechanistic characterization, it is not a classical or pharmacological drug target for human disease, and no drugs are clinically targeted to this enzyme.

Other names
NDO alpha subunitNaphthalene dioxygenase oxygenase component alpha subunitNaphthalene 1,2-dioxygenase large oxygenase component
02

Mechanism of action

Catalyzes the cis-dihydroxylation of aromatic rings by incorporating both atoms of molecular oxygen to form cis-dihydrodiols Functions via a Rieske [2Fe-2S] cluster and nonheme iron active site mechanism, with electron transfer from NAD(P)H via associated reductase and ferredoxin components

03

Biological functions

Aromatic ring hydroxylation (cis-dihydroxylation of naphthalene, biphenyl, phenanthrene, and related PAHs)Biodegradation of polycyclic aromatic hydrocarbons (PAHs) in bacteriaBiocatalytic formation of chiral synthons for chemical synthesis
04

Disease associations

Other (environmental pollutant degradation; no direct disease association in humans)
05

Safety considerations

None directly relevant for human therapy; in environmental application, only concerns would be general safety in bioremediation/biotechnology (not typically applicable to human toxicology or adverse effects)
06

Interacting drugs

None with clinical or therapeutic application; interacts with a wide range of aromatic hydrocarbons and environmental pollutants, such as: naphthalene, biphenyl, phenanthrene, anthracene, 3-nitrotoluene, phenetole, thioanisole, ethylphenylsulfide (for structural studies)
07

Biomarkers

None (not used in clinical or diagnostic human biomarker panels)

Beyond the preview

Go deeper on Naphthalene 1,2-dioxygenase subunit alpha (NDO alpha subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naphthalene 1,2-dioxygenase subunit alpha (NDO alpha subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call